EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nitroxoline Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Suppressing STAT3-AKT-MTOR Survival Signaling

Eun-Young Gong, Hye Won Lee iD, Hyunseung Oh iD, Jae-Ho Lee iD, Sang Jun Byun iD, Jeong-Woo Hwang, Sung Uk Bae, Hyowon Hong, Young Woo Do

International Journal of Molecular Sciences · 09.03.2026 · 27 (5) · 2504

DOI: 10.3390/ijms27052504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.03.2026. Verfasst von Eun-Young Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Keimyung University School of Medicine, Daegu 1095, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, STAT3 Transcription Factor, Signal Transduction, Nitroquinolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biomedical Research Institute, Kyungpook National University Hospital, Biomedical Research Institute grant, Kyungpook National University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is the central component in non-small cell lung cancer (NSCLC) treatment. Nonetheless, its therapeutic effectiveness is frequently compromised by adaptive engagement of prosurvival signaling pathways that foster radioresistance. STAT3 functions as the central signaling node that orchestrates cellular survival responses following radiation exposure. This study investigated whether nitroxoline, a clinically approved antimicrobial agent with STAT3-inhibitory activity, enhances radiosensitivity of NSCLC cells and how these effects are mechanistically regulated. We examined the combined effects of nitroxoline and radiation on cell viability and associated signaling pathways in NSCLC cells. Nitroxoline significantly enhanced radiation-induced cytotoxicity and suppressed clonogenic survival compared with radiation alone. Irradiation increased STAT3, AKT, and mTOR phosphorylation, whereas nitroxoline effectively suppressed the basal and radiation-induced activation of these pathways. The combination treatment markedly augmented radiation-induced apoptosis, as demonstrated by increased p53 expression and enhanced PARP and caspase-3 cleavage. Additionally, nitroxoline amplified radiation-induced DNA damage signaling, resulting in pronounced γ-H2AX and DNA-PKcs accumulation. Nitroxoline enhanced NSCLC cell radiosensitivity by suppressing STAT3–AKT–mTOR survival signaling, promoting apoptosis, and amplifying radiation-induced DNA damage, indicating the potential of repurposing nitroxoline as a radiosensitizer to improve radiotherapy outcomes in patients with NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungSTAT3 Transcription FactorSignal TransductionNitroquinolinesProto-Oncogene Proteins c-aktLung NeoplasmsRadiation ToleranceTOR Serine-Threonine KinasesRadiation-Sensitizing AgentsHumansCell Line, TumorApoptosisCell Survival

Stichwörter der Autor:innen

AKTSTAT3mTORnitroxolinenon-small cell lung cancerradiosensitivityradiosensitizer

Substanzen

STAT3 Transcription FactorNitroquinolinesnitroxolineProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesRadiation-Sensitizing AgentsMTOR protein, humanSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Keimyung University School of Medicine, Daegu 1095, Republic of Korea.
  • Department of Pathology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan 15355, Republic of Korea.
  • Department of Anatomy, Keimyung University School of Medicine, Daegu 1095, Republic of Korea.
  • Department of Radiation Oncology, Keimyung University School of Medicine, Daegu 1095, Republic of Korea.
  • Department of Surgery, Keimyung University School of Medicine, Daegu 1095, Republic of Korea.
  • Institute of Medical Science & Institute for Cancer Research, Keimyung University, Daegu 1095, Republic of Korea.

ORCID-Profile: Hye Won Lee, Hyunseung Oh, Jae-Ho Lee, Sang Jun Byun

Förderung

  • Biomedical Research Institute, Kyungpook National University Hospital
  • Biomedical Research Institute grant, Kyungpook National University Hospital

Zitieren

APA

Gong, E. Y., Lee, H. W., Oh, H., Lee, J. H., Byun, S. J., Hwang, J. W., Bae, S. U., Hong, H., & Do, Y. W. (2026). Nitroxoline Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Suppressing STAT3-AKT-MTOR Survival Signaling. International Journal of Molecular Sciences, 27(5), 2504. https://doi.org/10.3390/ijms27052504

Vancouver

Gong EY, Lee HW, Oh H, Lee JH, Byun SJ, Hwang JW, et al. Nitroxoline Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Suppressing STAT3-AKT-MTOR Survival Signaling. International Journal of Molecular Sciences. 2026;27(5):2504. doi:10.3390/ijms27052504

BibTeX
@article{Gong2026,
  author = {Gong, Eun-Young and Lee, Hye Won and Oh, Hyunseung and Lee, Jae-Ho and Byun, Sang Jun and Hwang, Jeong-Woo and Bae, Sung Uk and Hong, Hyowon and Do, Young Woo},
  title = {Nitroxoline Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Suppressing STAT3-AKT-MTOR Survival Signaling},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2504},
  doi = {10.3390/ijms27052504}
}
Kostenlos starten →